AngioDynamics to sell 2.4 million shares

New York, May 2 - AngioDynamics, Inc. plans to offer 2.4 million shares in a follow-on offering, according to an S-3 filing with the Securities and Exchange Commission.

RBC Capital Markets is the lead manager, with Canaccord Adams, First Albany Capital and KeyBanc Capital Markets as co-managers.

Proceeds will be used for possible acquisitions of complementary businesses and technologies, for working capital and for other general corporate purposes.

AngioDynamics is a Queensbury, N.Y., maker of therapeutic and diagnostic medical devices to treat peripheral vascular disease and other non-coronary diseases.

Its stock closed at $29.69 Tuesday.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.